ArticleJournal of diabetes investigation2022

Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world retrospective administrative database analysis in Japan.

Atsunori Kashiwagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.